M. Odinak, I. Voznyuk, A. Kuznetsov, S. Yanishevsky, O. Esipova
(Кафедра неврологии ВМА им. С. М. Кирова МО РФ, Санкт-Петербург)
Presented information reflects fundamental regulations of therapeutic strategy in cerebral ischemia, based on results of modern experimental and clinical studies. Comparative analysis of drugs, promoting preservation of the brain susbstance mass, structures of the blood-brain barrier in an acute period of ischemia, as well as of their efficacy is given. An optimum combination of drugs, whose timely use allows to reduce duration of an acute period, mortality and invalidism, is discussed.